Your browser doesn't support javascript.
loading
Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial.
Suh, Chang-Hee; Yoo, Dae Hyun; Berrocal Kasay, Alfredo; Chalouhi El-Khouri, Elia; Cons Molina, Francisco Fidenci; Shesternya, Pavel; Miranda, Pedro; Medina-Rodriguez, Francisco G; Wiland, Piotr; Jeka, Slawomir; Chavez-Corrales, Jose; Linde, Thomas; Hrycaj, Pawel; Abello-Banfi, Mauricio; Hospodarskyy, Ihor; Jaworski, Janusz; Piotrowski, Mariusz; Brzosko, Marek; Krogulec, Marek; Shevchuk, Sergii; Calvo, Armando; Andersone, Daina; Park, Won; Shim, Seung Cheol; Lee, Sang Joon; Lee, Sung Young.
Afiliação
  • Suh CH; Department of Rheumatology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Yoo DH; Division of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, 222-1 Wangsimni-Ro, Seongdong-Gu, Seoul, 04763, Republic of Korea. dhyoo@hanyang.ac.kr.
  • Berrocal Kasay A; ABK Reuma SRL-Medicentro Biociencias, Lima, Peru.
  • Chalouhi El-Khouri E; Clinica Internacional, Lima, Peru.
  • Cons Molina FF; Centro de Investigación en Artritis y Osteoporosis, Mexicali, Mexico.
  • Shesternya P; Krasnoyarsk State Medical University, Krasnoyarsk, Russia.
  • Miranda P; Centro de Estudios Reumatológicos, Santiago, Chile.
  • Medina-Rodriguez FG; La Salle University, Mexico City, Mexico.
  • Wiland P; Medical University of Wroclaw, Wroclaw, Poland.
  • Jeka S; Department of Rheumatology and Connective Tissue Diseases, University Hospital No. 2, Collegium Medicum UMK, Bydgoszcz, Poland.
  • Chavez-Corrales J; Clinica San Borja, Lima, Peru.
  • Linde T; MVZ für Rheumatologie und Autoimmundiagnostik, Halle (Salle), Germany.
  • Hrycaj P; Department of Rheumatology, Koscian Municipal Hospital, Koscian, Poland.
  • Abello-Banfi M; Centro Integral de Reumatologia del Caribe, Barranquilla, Colombia.
  • Hospodarskyy I; Ternopil State Medical University, Ternopil, Ukraine.
  • Jaworski J; Reumatika-Centrum Reumatologii, Warsaw, Poland.
  • Piotrowski M; Department of Rheumatology, Medical University of Lublin, Lublin, Poland.
  • Brzosko M; Department of Rheumatology, Internal Diseases and Geriatrics, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Krogulec M; Rheumatology Clinic MAK-MED, Nadarzyn, Poland.
  • Shevchuk S; National Pirogov Memorial Medical University, Vinnytsya, Ukraine.
  • Calvo A; Centro de Investigación Clínica Inunoreumatología, Clínica San Felipe, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Andersone D; University of Latvia, Riga, Latvia.
  • Park W; School of Medicine, Medicine/Rheumatology, IN-HA University, Incheon, Republic of Korea.
  • Shim SC; Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea.
  • Lee SJ; CELLTRION, Inc., Incheon, Republic of Korea.
  • Lee SY; CELLTRION, Inc., Incheon, Republic of Korea.
BioDrugs ; 33(1): 79-91, 2019 Feb.
Article em En | MEDLINE | ID: mdl-30719632

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Anticorpos Monoclonais Murinos / Medicamentos Biossimilares / Rituximab Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Anticorpos Monoclonais Murinos / Medicamentos Biossimilares / Rituximab Idioma: En Ano de publicação: 2019 Tipo de documento: Article